Cardiol Therapeutics's market cap is currently $90.07M. The company's EPS TTM is $-0.0717141; its P/E ratio is ―; Cardiol Therapeutics is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
